Vaccinating the World One Collaboration at a Time

Positive global health outcomes are often contingent on more than just great science, as knowledge sharing is also a fundamental part of achieving public health goals. With drug resistance on the rise for many pathogens once thought well managed clinically, scientists are looking toward the development of new vaccines to help reduce morbidity and mortality for many global diseases. Collaboration between academia, industry, suppliers, and government organizations is crucial for the successful development of these vaccines, as these intellectual exchanges help accelerate production timelines, reduce costs, and increase chances of bringing an essential vaccine to market.

Panelists:

Bart Fryszczyn
Process Development Scientist
MilliporeSigma

Victor Abramant
Process Development Scientist
MilliporeSigma

Luciana Cezar De Cerqueira Leite
Director of Vaccine Development Library
Butantan Institute

Maria Elena Bottazzi
Co-Director, Texas Children’s Hospital Center for Vaccine Development
Baylor College of Medicine

Zhuyun Liu
Director Process Development Unit
Texas Children’s Hospital Center for Vaccine Development at Baylor College of Medicine